Comparison of effects of pitavastatin and atorvastatin on glucose and lipid metabolism in diabateic patients with hyperlipidemia

Comparison of effects of pitavastatin and atorvastatin on glucose and lipid metabolism in diabateic patients with hyperlipidemia - the effect of statin on glucose metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003554

Enrollment

Registered

2010-05-01

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetic patients with hyperlipidemia

Interventions

pitavastatin 12-16week atorvastatin 12-16week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 2 patients with rosuvastatin for more 4 weeks 2 HbA1c<7.0

Exclusion criteria

Exclusion criteria: 1) severe hepatic or renal failure 2) patients with uncontrolled hypertension 3) patients with insulin 4) Patients with a history of CHD 5) pregnant women 6) patients deemed not appropriate for study entry by the investigator.

Design outcomes

Primary

Measure	Time frame
HbA1c, glucose, lipoprotein	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026